Edition:
United Kingdom

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Capital Market

3.83USD
3:33pm BST
Change (% chg)

$-0.13 (-3.28%)
Prev Close
$3.96
Open
$3.96
Day's High
$4.04
Day's Low
$3.83
Volume
10,159
Avg. Vol
85,929
52-wk High
$12.58
52-wk Low
$2.74

About

Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic vaccine, which is meant for the... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $405.56
Shares Outstanding(Mil.): 128.34
Dividend: --
Yield (%): --

Financials

  CLDX.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.10 -- --
ROI: -43.88 8.91 13.83
ROE: -53.51 10.06 15.25

Earnings vs. Estimates